Feasibility and safety
neutropenia
NEUTROPENIA, POSTOPERATIVE COMPLICATIONS, ADVERSE EVENT, EVENTS, COMPLICATIONS
All patients received a mean of 2.6 cycles of neoadjuvant treatment. Adverse events occurred in all patients, but only two events were of grade 3 or higher (neutropenia; Supplementary Fig. Among 20 patients who underwent surgery, the median interval between the last dose of apatinib and surgery was 16 days (Quartiles, 14–19 days; Fig. Seven patients (35%) experienced grade 1 or 2 postoperative complications, and there were no grade 3 or higher complications (Supplementary Fig. 